These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 1688685)
1. Drusen as risk factors in age-related macular disease. Pauleikhoff D; Barondes MJ; Minassian D; Chisholm IH; Bird AC Am J Ophthalmol; 1990 Jan; 109(1):38-43. PubMed ID: 1688685 [TBL] [Abstract][Full Text] [Related]
2. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Bressler SB; Maguire MG; Bressler NM; Fine SL Arch Ophthalmol; 1990 Oct; 108(10):1442-7. PubMed ID: 1699513 [TBL] [Abstract][Full Text] [Related]
3. [Drusen and their significance in age related macular degeneration]. Pauleikhoff D; Barondes M; Minassian D; Chrisholm J; Wessing A; Bird AC Fortschr Ophthalmol; 1990; 87(5):429-32. PubMed ID: 2272567 [TBL] [Abstract][Full Text] [Related]
4. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology; 1998 Jan; 105(1):11-23. PubMed ID: 9442774 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic laser treatment to fellow eyes of unilateral retinal pigment epithelial tears. Gross-Jendroska M; Owens SL; Flaxel CJ; Guymer RH; Bird AC Am J Ophthalmol; 1998 Jul; 126(1):77-81. PubMed ID: 9683152 [TBL] [Abstract][Full Text] [Related]
6. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study. Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000 [TBL] [Abstract][Full Text] [Related]
13. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration. Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089 [TBL] [Abstract][Full Text] [Related]
14. [Drusen in Bruch's membrane. Their significance for the pathogenesis and therapy of age-associated macular degeneration]. Pauleikhoff D Ophthalmologe; 1992 Oct; 89(5):363-86. PubMed ID: 1304217 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512 [TBL] [Abstract][Full Text] [Related]
16. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Holz FG; Wolfensberger TJ; Piguet B; Gross-Jendroska M; Wells JA; Minassian DC; Chisholm IH; Bird AC Ophthalmology; 1994 Sep; 101(9):1522-8. PubMed ID: 8090455 [TBL] [Abstract][Full Text] [Related]
17. Oral zinc and the second eye in age-related macular degeneration. Stur M; Tittl M; Reitner A; Meisinger V Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1225-35. PubMed ID: 8641826 [TBL] [Abstract][Full Text] [Related]
18. Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss. Schatz H; McDonald HR Ophthalmology; 1989 Oct; 96(10):1541-51. PubMed ID: 2587050 [TBL] [Abstract][Full Text] [Related]